Research has demonstrated that Hosokawa Micron's Modulomix continuous pharma mixer is suitable to be used in the manufacture of extended release (ER) tablets with desired quality attributes via integrated continuous mixing and direct compression.
The research was conducted by the University of Eastern Finland in Kuopio and pharmaceutical company AstraZeneca. The results were published in the International Journal of Pharmaceutics (Volume 495, Issue 1, 10 November 2015, Pages 290-301).
The study was span out with a challenging formulation design comprising ibuprofen compositions with varying particle size and a relatively low amount of the matrix former hydroxypropyl methylcellulose (HPMC). Standard grade HPMC (CR) was compared to a recently developed direct compressible grade (DC2).